Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines

Ítems similars

• Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
  per: Atossa Shaltouki, et al.
  Publicat: (2015-05-01)
• Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
  per: Atossa Shaltouki, et al.
  Publicat: (2015-05-01)
• A platform for rapid generation of single and multiplexed reporters in human iPSC lines
  per: Pei, Ying, et al.
  Publicat: (2015)
• Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
  per: Momcilovic, Olga, et al.
  Publicat: (2016)
• Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
  per: Okarmus, Justyna, et al.
  Publicat: (2021)